{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T10:08:48Z","timestamp":1768644528792,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.ophtha.2004.05.031","type":"journal-article","created":{"date-parts":[[2004,12,10]],"date-time":"2004-12-10T14:36:13Z","timestamp":1102689373000},"page":"2224-2231.e3","source":"Crossref","is-referenced-by-count":78,"title":["Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy"],"prefix":"10.1016","volume":"111","author":[{"given":"Douglas A.","family":"Jabs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark L.","family":"Van Natta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer E.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David V.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis A.","family":"Meredith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baruch D.","family":"Kuppermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent","family":"Sepkowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen K.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2004.05.031_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2004.05.031_bib2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.7326\/0003-4819-130-7-199904060-00005","article-title":"Relations among CD4 lymphocyte count nadir, antiretroviral therapy, and HIV-1 disease progression","volume":"130","author":"Miller","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ophtha.2004.05.031_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-135-1-200107030-00005","article-title":"Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease","volume":"135","author":"Murphy","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ophtha.2004.05.031_bib4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.7326\/0003-4819-133-6-200009190-00007","article-title":"Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy","volume":"133","author":"Grabar","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ophtha.2004.05.031_bib5","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.286.20.2560","article-title":"HIV","volume":"286","author":"Phillips","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2004.05.031_bib6","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1001\/jama.286.20.2568","article-title":"Rates of disease progression by baseline CD4","volume":"286","author":"Hogg","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2004.05.031_bib7","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nm0898-953","article-title":"Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1","volume":"4","author":"Komanduri","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.ophtha.2004.05.031_bib8","unstructured":"Guidelines for preventing opportunistic infections among HIV-infected persons\u20142002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 2002;51(RR-8):1\u201352."},{"key":"10.1016\/j.ophtha.2004.05.031_bib9","first-page":"623","article-title":"Ocular manifestations of HIV infection","volume":"93","author":"Jabs","year":"1995","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2004.05.031_bib10","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/infdis\/166.6.1223","article-title":"Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine","volume":"166","author":"Gallant","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2004.05.031_bib11","first-page":"1069","article-title":"Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus","volume":"5","author":"Pertel","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ophtha.2004.05.031_bib12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archopht.1996.01100140035004","article-title":"Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression","volume":"114","author":"Hoover","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.031_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0002-9394(14)70789-5","article-title":"AIDS and ophthalmology: a period of transition","volume":"124","author":"Jabs","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.031_bib14","first-page":"1931","article-title":"Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997","volume":"12","author":"Holtzer","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.ophtha.2004.05.031_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1086\/313612","article-title":"Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy","volume":"30","author":"Jacobson","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ophtha.2004.05.031_bib16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0002-9394(98)00285-2","article-title":"Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy","volume":"126","author":"Jabs","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.031_bib17","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1086\/517399","article-title":"Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus\u2013infected patients","volume":"177","author":"Tural","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2004.05.031_bib18","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1086\/515281","article-title":"Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy","volume":"177","author":"Macdonald","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2004.05.031_bib19","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.282.17.1633","article-title":"Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis","volume":"282","author":"Whitcup","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2004.05.031_bib20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00002030-200001280-00013","article-title":"CMV retinitis recurs after stopping treatment in virological and immunological failure of potent antiretroviral therapy","volume":"14","author":"Torriani","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.ophtha.2004.05.031_bib21","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1086\/319219","article-title":"Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient despite potent antiretroviral therapy and apparent immune reconstitution","volume":"32","author":"Johnson","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ophtha.2004.05.031_bib22","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/319683","article-title":"Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis","volume":"183","author":"Komanduri","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2004.05.031_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/0003-4819-137-4-200208200-00008","article-title":"Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy","volume":"137","author":"Kirk","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ophtha.2004.05.031_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0002-9394(01)01322-8","article-title":"Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"133","author":"Jabs","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.031_bib25","first-page":"33","article-title":"Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome","volume":"119","author":"Kempen","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.031_bib26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archopht.121.4.466","article-title":"Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immune deficiency syndrome","volume":"121","author":"Kempen","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.031_bib27","unstructured":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41(RR-17):1\u201319."},{"key":"10.1016\/j.ophtha.2004.05.031_bib28","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L","article-title":"The use of the nitrogen mustards in the palliative treatment of carcinoma","volume":"1","author":"Karnofsky","year":"1948","journal-title":"Cancer"},{"key":"10.1016\/j.ophtha.2004.05.031_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0197-2456(92)90027-W","article-title":"Studies of Ocular Complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1","volume":"13","year":"1992","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ophtha.2004.05.031_bib30","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0002-9394(00)00356-1","article-title":"Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis following highly active antiretroviral therapy","volume":"129","author":"Nguyen","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.031_bib31","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1128\/JCM.37.5.1431-1435.1999","article-title":"Comparison of cytomegalovirus loads in plasma and leukocytes of patients with cytomegalovirus retinitis","volume":"37","author":"Jabs","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ophtha.2004.05.031_bib32","series-title":"Statistical Methods in Medical Research","author":"Armitage","year":"1987"},{"key":"10.1016\/j.ophtha.2004.05.031_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"10.1016\/j.ophtha.2004.05.031_bib34","series-title":"SAS\/STAT User's Guide Version 8.0","year":"2000"},{"key":"10.1016\/j.ophtha.2004.05.031_bib35","unstructured":"Stata Statistical Software [computer program]. Release 6.0. College Station, TX: Stata Corp.; 1999."},{"key":"10.1016\/j.ophtha.2004.05.031_bib36","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7326\/0003-4819-124-7-199604010-00003","article-title":"Natural history of opportunistic disease in an HIV-infected urban clinical cohort","volume":"124","author":"Moore","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ophtha.2004.05.031_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archopht.1996.01100130021004","article-title":"Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS","volume":"114","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.031_bib38","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/archopht.1997.01100160698006","article-title":"MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome","volume":"115","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.031_bib39","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archopht.118.9.1196","article-title":"Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome","volume":"118","author":"Holbrook","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2004.05.031_bib40","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/infdis\/168.6.1506","article-title":"Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy","volume":"168","author":"Kuppermann","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2004.05.031_bib41","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/infdis\/172.4.951","article-title":"Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis","volume":"172","author":"Arevalo","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2004.05.031_bib42","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1086\/314943","article-title":"Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy","volume":"180","author":"O'Sullivan","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2004.05.031_bib43","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/00002030-199907090-00008","article-title":"Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy","volume":"13","author":"Deayton","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.ophtha.2004.05.031_bib44","doi-asserted-by":"crossref","first-page":"8642","DOI":"10.1073\/pnas.84.23.8642","article-title":"Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus","volume":"84","author":"Davis","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ophtha.2004.05.031_bib45","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/infdis\/157.3.508","article-title":"Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus","volume":"157","author":"Skolnik","year":"1988","journal-title":"J Infect Dis"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642004009327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642004009327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T07:16:58Z","timestamp":1734765418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642004009327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0161642004009327"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2004.05.031","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}